Randall Michael Giuffre Dia Medica Therapeutics Inc. (DMAC) insider trading activity
Randall Michael Giuffre is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 375,412 shares of DMAC, which is worth approximately $2.21 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 10,861 shares (Voting Common Shares, no par value per share) at a price of $5.34 per share, resulting in proceeds of $57,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
375K
2.98%
3M change
2.98%
12M change
Total Value Held
$2.21 Million
Randall Michael Giuffre Transaction History
RMG
Randall Michael Giuffre
Director
Minneapolis, MN